Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06529120 | Adaptation and Pilot Testing of a Mindfulness-Based Insomnia and Symptom Management Intervention for Women With Breast Cancer Receiving Treatment in Rural Medically Underserved Areas | completed | N/A | 15 | Duke UniversityOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT07691294 | Endoscopic Assisted Latissimus Dorsi Musculocutaneous Flap for Breast Reconstruction | completed | N/A | 15 | Kasr El Aini HospitalOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT02200705 | Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial | completed | N/A | 206 | IceCure Medical Ltd.INDUSTRY | 1 | Jul 7, 2026 | clinicaltrials |
| NCT03664687 | Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)(REaCT-ZOL) | completed | Phase 4 | 211 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT06161922 | Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy | completed | — | 600 | Fudan UniversityOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT06177795 | Increasing Screening for Cancer Using EHR-Nudges(I-SCREEN) | completed | N/A | 21,123 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT06745804 | Study of 68Ga-R10602 | completed | Phase 1 | 27 | Radionetics OncologyINDUSTRY | 1 | Jul 6, 2026 | clinicaltrials |
| NCT00317720 | Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer | completed | Phase 1 / Phase 2 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT02867475 | REduction of Physical Inactivity Facing the CAncer(RESCA) | completed | N/A | 420 | Centre Antoine LacassagneOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT03121469 | Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer(RPOS+) | completed | N/A | 28 | Centre Antoine LacassagneOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT04000880 | Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health(AMPLIFY) | completed | N/A | 603 | University of Alabama at BirminghamOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT04213365 | Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol)(COG STIM) | completed | N/A | 20 | Centre Francois BaclesseOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT04261153 | Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study(COG-TAB-AGE) | completed | N/A | 55 | Centre Francois BaclesseOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT07680296 | NIR Device for Assessment of Skin Flap Perfusion in Breast Surgery: A Pilot Interventional Study(ADisIRast) | completed | N/A | 20 | National Research Council, Institute of Clinical Physiology, ItalyOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT07680855 | ANTthracycline-induced Inflammation and OXidative Stress: 10-year Follow-up(ANTIOX-10) | completed | — | 17 | University of ChileOTHER | 0 | Jul 2, 2026 | clinicaltrials |
| NCT03179904 | TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer | completed | Phase 2 | 17 | Mayo ClinicOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07678099 | Screening Colonoscopy in Breast Cancer Patients | completed | N/A | 216 | Haydarpasa Numune Training and Research HospitalOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT05043506 | European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies(EUCHARIS) | completed | — | 1,939 | PfizerINDUSTRY | 7 | Jun 30, 2026 | clinicaltrials |
| NCT07671547 | Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy(NADERIN-BC) | completed | Phase 2 / Phase 3 | 79 | MIPO ClinicOTHER | 0 | Jun 30, 2026 | clinicaltrials |
| NCT00165256 | Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast | completed | Phase 2 | 157 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT00861705 | Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery | completed | Phase 2 | 454 | National Cancer Institute (NCI)NIH | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06156397 | The Effect of Technological Based Rehabilitation Practices After Breast Cancer Surgery | completed | N/A | 45 | Medipol UniversityOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06340503 | Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors | completed | N/A | 20 | Wake Forest University Health SciencesOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06534957 | Online Mindfulness-based Stress Reduction for Patients Receiving Chemotherapy | completed | N/A | 128 | Medicos e Investigadores en la Lucha contra el Cancer de MamaOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT01750073 | Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer | completed | Phase 2 | 92 | University of NebraskaOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT01805076 | MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer | completed | Phase 3 | 319 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT03323346 | Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer(DISC) | completed | Phase 2 | 9 | The Institute of Molecular and Translational Medicine, Czech RepublicOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT05940298 | Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8 | completed | Phase 1 | 10 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT06096623 | The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment | completed | — | 100 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT02206334 | Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer | completed | Phase 1 | 42 | NRG OncologyOTHER | 3 | Jun 25, 2026 | clinicaltrials |
| NCT03271476 | EMDR Psychotherapy to Treat Anxious-depressive Symptoms in Breast Cancer Patient(PSYCANCER) | completed | N/A | 15 | Centre Hospitalier Régional Metz-ThionvilleOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT03326713 | Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project(GRACE) | completed | N/A | 668 | Rutgers, The State University of New JerseyOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT05185947 | Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Jun 25, 2026 | clinicaltrials |
| NCT06791018 | Cancer Exercise: Evaluation of a Mobile App in Breast Cancer Survivors | completed | N/A | 132 | University of AlbertaOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT07668076 | The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients | completed | Phase 2 | 44 | Damanhour UniversityOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT03991260 | 99mTc-ADAPT6-based HER2 Imaging in Breast Cancer(99mTc-ADAPT6) | completed | — | 16 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT04817501 | Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System(CTCs) | completed | — | 150 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT05412446 | 99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes(99mTc-ADAPT6) | completed | Phase 2 | 30 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT05412459 | 99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy | completed | — | 15 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT06874985 | Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation | completed | N/A | 1,264 | International Agency for Research on CancerOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT00785291 | Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer | completed | Phase 3 | 799 | National Cancer Institute (NCI)NIH | 2 | Jun 23, 2026 | clinicaltrials |
| NCT02792465 | A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors | completed | Phase 1 | 52 | University Health Network, TorontoOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT04456920 | Pain Monitoring After Breast Biopsy: Benefit of E-health(BIO-PSY) | completed | N/A | 193 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT05297773 | Resistance vs. Aerobic Training on Breast Cancer Patients Undergoing Neoadjuvant Treatment(NEO-Program) | completed | N/A | 132 | Fundacao ChampalimaudOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07068477 | Adaptation of a Values Assessment Tool | completed | N/A | 67 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT02926547 | New Approaches for the Identification and Characterization of Functional Markers of the Risk of Extension of Breast Cancer Without Lymph Node Involvement | completed | — | 108 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT05269186 | Interest of Virtual Reality on Anxiety Before the Planning CT Scan in Radiotherapy(REAVA) | completed | N/A | 256 | Centre Hospitalier Departemental VendeeOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT05708950 | A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) | completed | Phase 1 / Phase 2 | 40 | Kineta Inc.INDUSTRY | 1 | Jun 18, 2026 | clinicaltrials |
| NCT06006299 | Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC) | completed | Phase 1 | 20 | University of Alabama at BirminghamOTHER | 1 | Jun 18, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Jul 8, 2026source: clinicaltrials